Directory
>
George Mulligan
George Mulligan
Chief Scientific Officer | Multiple Myeloma Research Foundation - MMRF
Boston, Massachusetts, United States
George Mulligan
Summary
George Mulligan is an accomplished Chief Scientific Officer with over 20 years of experience in clinical drug development, specializing in oncology and rare diseases. His extensive background allows him to integrate scientific principles with strategic partnerships to tackle the complexities of developing new therapies. George is passionate about improving patient outcomes and has a track record of leading teams to success in biomarker research and drug development. He has held key leadership roles in several pharmaceutical companies, including Takeda and Mitobridge, where he focused on translational medicine and innovative therapeutic strategies. His academic credentials include a PhD in Cellular and Developmental Biology from Stony Brook University and post-doctoral studies at MIT. George is known for his ability to navigate complex regulatory environments and foster collaboration across multidisciplinary teams. He is committed to advancing the field of pharmaceutical research and is particularly interested in the intersection of science and patient care.
George Mulligan
Work Experience
Chief Scientific Officer at
Multiple Myeloma Research Foundation - MMRF
March 2022 - Present
Chief Development Officer (CDO) at
Bantam Pharmaceutical
October 2021 - March 2022
Chief Scientific Officer Mitobridge, an Astellas Co. at
Astellas Pharma Global Development, Inc.
July 2020 - December 2020
Senior Vice President at
Astellas Pharma Global Development, Inc.
October 2015 - May 2020
Senior Director Translational Medicine at
Takeda Pharmaceuticals America, Inc.
September 2014 - October 2015
Director Translational Medicine at
Takeda Pharmaceuticals America, Inc.
April 2007 - September 2014
Senior Scientist at
MILLENNIUM PHARMACEUTICALS, INC.
February 2000 - October 2007
Senior Research Sceintist at
Aventis
January 1999 - January 2000
Senior Research Scientist at
Takeda Pharmaceuticals America, Inc.
January 1998 - January 1999
George Mulligan
Education
MIT Center for Cancer Research, Post-Doctoral Studies
State University of New York- Stony Brook, Doctor Of Philosophy (Phd)
Fordham University, Bachelor Of Science (Bs)
Frequently Asked Questions about George Mulligan
What is George Mulligan email address?
George Mulligan's primary email address is *********@themmrf.org. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does George Mulligan work for?
George Mulligan is a Chief Scientific Officer at Multiple Myeloma Research Foundation - MMRF, a company specializing in Real estate agents & managers.
Where George Mulligan graduated from?
George Mulligan holds a degree in Mouse Models Of Tumor Supporessor And Oncogene Function (Tyler Jacks Lab) from MIT Center for Cancer Research.
How can I directly contact George Mulligan?
To contact George Mulligan directly, you can use the email address *********@themmrf.org. Complete contact information is available upon registration with Muraena.
Who is George Mulligan?
George Mulligan is an accomplished Chief Scientific Officer with over 20 years of experience in clinical drug development, specializing in oncology and rare diseases. His extensive background allows him to integrate scientific principles with strategic partnerships to tackle the complexities of developing new therapies. George is passionate about improving patient outcomes and has a track record of leading teams to success in biomarker research and drug development. He has held key leadership roles in several pharmaceutical companies, including Takeda and Mitobridge, where he focused on translational medicine and innovative therapeutic strategies. His academic credentials include a PhD in Cellular and Developmental Biology from Stony Brook University and post-doctoral studies at MIT. George is known for his ability to navigate complex regulatory environments and foster collaboration across multidisciplinary teams. He is committed to advancing the field of pharmaceutical research and is particularly interested in the intersection of science and patient care.
George`s contact details
*********@themmrf.org
***************@mpi.com
***************@takeda.com
*********@mitobridge.com
Colleagues
President & Chief Executive Officer
Rare As One Program Mentor
Vice President, Clinical Research
VP Business Development/Alliance Management
Vice President, Marketing & Communications
Clinical Professor of Medicine
Member of Board of Directors, Chair of Risk Committee